Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

CNQ

Exploring Canadian Natural Resources Stock Insights

It hasn't been a great morning session for Canadian Natural Resources investors, who have watched their shares sink by -1.7% to a price of $31.45. Some of you might be wondering if it's time to buy the dip. If you are considering this, make sure to check the company's fundamentals first to determine if the shares are fairly valued at today's prices.

Canadian Natural Resources Is Currently Undervalued:

Canadian Natural Resources Limited engages in the acquisition, exploration, development, production, marketing, and sale of crude oil, natural gas, and natural gas liquids (NGLs) in Western Canada, the United Kingdom sector of the North Sea, and Offshore Africa. The company belongs to the Energy sector, which has an average price to earnings (P/E) ratio of 18.35 and an average price to book (P/B) ratio of 1.6. In contrast, Canadian Natural Resources has a trailing 12 month P/E ratio of 11.0 and a P/B ratio of 1.59.

Canadian Natural Resources has moved -6.4% over the last year compared to 16.2% for the S&P 500 — a difference of -22.6%. Canadian Natural Resources has a 52 week high of $37.91 and a 52 week low of $24.65.

Generally Positive Cash Flows but Not Enough Current Assets to Cover Current Liabilities:

2019 2020 2021 2022 2023 2024
Revenue (M) $22,871 $16,893 $30,057 $42,298 $35,968 $35,656
Net Margins 24% -3% 25% 26% 23% 17%
Net Income (M) $5,416 -$435 $7,664 $10,937 $8,233 $6,106
Net Interest Expense (M) -$836 -$756 -$711 -$549 -$636 -$592
Depreciation & Amort. (M) $5,546 $6,046 $5,724 $7,353 $6,413 $6,681
Earnings Per Share $4.54 -$0.37 $6.46 $4.76 $3.74 $2.85
EPS Growth n/a -108.15% 1845.95% -26.32% -21.43% -23.8%
Free Cash Flow (M) $8,829 $4,714 $14,478 $19,391 $12,353 $13,386
Total Debt (M) $18,591 $20,110 $13,694 $11,041 $9,819 $16,419
Current Ratio 0.68 0.86 0.8 0.82 0.96 0.77
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS